Premier Alternatives

Dewpoint Therapeutics

Boston, MA · Founded 2018 · Privately Held (backing)

Developer of an AI-powered healthcare technology platform designed to identify novel drugs across a wide spectrum of diseases. Dewpoint Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $500 million in Feb 2022. It has raised $345 million across 3 recorded rounds; the latest was a $59.1 million later-stage round in Sep 2025.

Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$345.3M
Last round
Later Stage VC
Sep 2025

Dewpoint Therapeutics key facts

as of Oct 2026
  • Developer of an AI-powered healthcare technology platform designed to identify novel drugs across a wide spectrum of diseases.
  • Dewpoint Therapeutics is valued at approximately $500.0M as of Oct 2026 (last reported valuation).
  • It has raised $345.3M across 3 recorded rounds; the latest was Later Stage VC ($59.1M) in Sep 2025.
  • Notable investors include General Catalyst, SoftBank Investment Advisers, Alexandria Venture Investments, Mirae Asset Capital, ARCH Venture Partners — 18 tracked in total.
  • Dewpoint Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently Sep 2025 ($59.1M sold to 21 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$500.0M

Dewpoint Therapeutics's last reported valuation, Feb 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Dewpoint Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch Dewpoint Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Dewpoint Therapeutics funding rounds

3 rounds
Sep 2025Later Stage VC$59.1MSEC filing▮
Jan 2022Later Stage VC$150.0MSEC filing▮
Jul 2020Later Stage VC$77.1MSEC filing▮
Full funding history →

Dewpoint Therapeutics valuation

Dewpoint Therapeutics's last reported valuation was $500 million in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Dewpoint Therapeutics raised?

Dewpoint Therapeutics has raised $345 million across 3 recorded rounds since 2020. The largest was a $77.1 million later-stage round in Jul 2020; the most recent was a $59.1 million later-stage round in Sep 2025.

Dewpoint Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Sep 2025 ($59.1 million sold to 21 investors).

Dewpoint Therapeutics investors

18 investors are on record for Dewpoint Therapeutics, including General Catalyst, SoftBank Investment Advisers, Alexandria Venture Investments and Mirae Asset Capital. By type, the record holds 7 venture capital firms, 2 hedge funds and 1 growth equity firm. The later-stage round in Sep 2025 drew 21 investors.

About Dewpoint Therapeutics

Developer of an AI-powered healthcare technology platform designed to identify novel drugs across a wide spectrum of diseases. The company's platform facilitates a proprietary end-to-end experimental platform and uses machine-learning-based image analysis tools for visualizing condensates to prevent harmful protein sequestration, enabling healthcare providers to have access to new therapies to address unmet needs.

Sector
Healthcare
HQ
Boston, MA, United States
Founded
2018
Employees
97
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.